Bio Pharma Dive
NOVEMBER 13, 2023
Regulatory agencies have set the framework and use cases for RWE. How can these increase the probability of success or efficiency in a pre-clinical and clinical drug development program?
Pharmaceutical Technology
NOVEMBER 13, 2023
As per the company, the candidate THIO, is the only direct telomere-targeting agent currently in clinical development.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
NOVEMBER 13, 2023
Trial results add to evidence that so-called Factor XIa inhibitors could have less bleeding risk than currently available oral anticoagulants like Xarelto.
Pharmaceutical Technology
NOVEMBER 13, 2023
At the BIO-Europe conference, experts discussed remaining challenges in AI healthcare interventions.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Bio Pharma Dive
NOVEMBER 13, 2023
Forge Biologics operates a contract manufacturing business as well as develops its own gene therapies, which appears to have attracted the Japan-based food and biotechnology company.
Pharmaceutical Technology
NOVEMBER 13, 2023
The UK government has announced £267m ($326.4m) funds for developing treatments for drug and alcohol misuse.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Bio Pharma Dive
NOVEMBER 13, 2023
With the deal, the Swiss pharma is exploring a tumor target, DLL3, that’s thwarted past drugmaker efforts to attack it.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 13, 2023
The Union Ministry of Ayush has come out with the revised guidelines governing the National Dhanwantari Ayurveda Award to be conferred to renowned ayurvedic practitioners, while celebrating the Ayurveda Day every year on the day of Dhanwantari Jayanti (Dhanteras).
Bio Pharma Dive
NOVEMBER 13, 2023
Shares in several heart device makers, which have been battered over the perceived impact of obesity medicines, rose this week following AHA data on Novo’s therapy.
Pharmaceutical Technology
NOVEMBER 13, 2023
The EMA CHMP provided a positive opinion for granting approval to Merck’s Keytruda combination therapy to treat biliary tract cancer.
Bio Pharma Dive
NOVEMBER 13, 2023
Explore how decentralized clinical trials (DCTs) can enhance rare disease research in three key ways.
pharmaphorum
NOVEMBER 13, 2023
Where old pathways to innovative cancer care fall short, a new model emerges Mike.
Bio Pharma Dive
NOVEMBER 13, 2023
As biopharmaceutical organizations around the globe adjust to the new guidelines, Baroni shared insights on four things they need to know about Annex 1.
Pharmaceutical Technology
NOVEMBER 13, 2023
Novo Nordisk announced this week that its weight loss drug Wegovy reduces the risk of major cardiovascular events by 20%.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Rethinking Clinical Trials
NOVEMBER 13, 2023
The NIH Pragmatic Trials Collaboratory published a new chapter of its Living Textbook of Pragmatic Clinical Trials this week. The chapter, “ Ethics and Equity for Artificial Intelligence and Machine Learning in Pragmatic Clinical Trials ,” describes key considerations and challenges with leveraging artificial intelligence and machine learning in pragmatic clinical trials.
Pharmaceutical Technology
NOVEMBER 13, 2023
On 8 November, Takeda announced it had received US Food and Drug Administration (FDA) approval for its oral Fruzaqla (fruquintinib) as a third-line treatment for adults with metastatic colorectal cancer (mCRC).
Antidote
NOVEMBER 13, 2023
Each November is designated as Diabetes Awareness Month , an event that highlights the importance of spreading awareness about diabetes and the health issues it can cause.
Pharmaceutical Technology
NOVEMBER 13, 2023
Heqet Therapeutics and Ethris have collaborated to develop RNA-based therapeutics to treat cardiovascular conditions.
pharmaphorum
NOVEMBER 13, 2023
Victoria Atkins replaces Barclay as UK health secretary Phil.
Pharmaceutical Technology
NOVEMBER 13, 2023
The UK government has seen a cabinet reshuffle as the Prime Minister removed Steve Barclay as UK health secretary and replaced him with Victoria Atkins.
Fierce Pharma
NOVEMBER 13, 2023
Novo Nordisk has made a splash with its GLP-1 drugs that have allowed patients to achieve significant weight loss. | Novo Nordisk has made a splash with its GLP-1 drugs that have allowed patients to achieve significant weight loss. Now the Danish company appears on the verge of another breakthrough, showing that the use of its obesity treatment Wegovy can reduce the risk of heart attack.
Pharmaceutical Technology
NOVEMBER 13, 2023
At the FT Global Pharma and Biotech Summit in London, various industry players shared their thoughts on technological and regulatory advancements.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
pharmaphorum
NOVEMBER 13, 2023
Akili says OTC switch for ADHD DTx leads to sales rise Phil.
Pharmaceutical Technology
NOVEMBER 13, 2023
Mirati Therapeutics has obtained EMA CHMP's positive opinion for Krazati to treat KRASG12C-mutated non-small cell lung cancer.
pharmaphorum
NOVEMBER 13, 2023
UCB on course for approval of gMG drug Rystiggo in EU Phil.
Pharmaceutical Technology
NOVEMBER 13, 2023
An upcoming two-day event will host talks on the impact of new technology on oncology trials and smaller biotechs.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
pharmaphorum
NOVEMBER 13, 2023
ADCs shine at ESMO ’23, as pharma makes case for early immunotherapy interventions Mike.
Pharmaceutical Technology
NOVEMBER 13, 2023
Ajinomoto has signed a definitive agreement for the acquisition of Forge Biologics in an all-cash transaction totalling $620m.
Fierce Pharma
NOVEMBER 13, 2023
Six months on, Teva’s new “pivot to growth” strategy appears to be paying off. | In 2023’s third quarter, the Israeli-American generics giant reported global sales of $3.9 billion, up 7% from the same period in 2022. The company credited that growth to the strong momentum behind its branded meds Austedo and Ajovy, plus a “stable and sustainable generics business” in the U.S. that’s also seen “continued growth” in Europe and other international markets.
Pharmaceutical Technology
NOVEMBER 13, 2023
Procaps studies show that by consuming Unigel® products, patients avoided the production and disposal of 27.5 million blister packs in 2022.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Expert insights. Personalized for you.
279 
Let's personalize your content